Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$748,880
+$202,546 QoQ
Shares Held
2,976
+18.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#2,820
of 4,153 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Alternative Capital holds $26,259,704 across 8 Drug Manufacturers - General names. ABBV ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,154 | $9,436,001 | |
| 2 | LLY |
ELI LILLY & Co
|
7,645 | $9,169,643 | |
| 3 | MRK |
Merck & Co., Inc.
|
39,979 | $5,137,301 | |
| 4 | AMGN |
Amgen Inc
|
3,151 | $1,141,040 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
2,976 | $748,880 | |
| 6 | PFE |
Pfizer Inc
|
13,063 | $314,557 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,189 | $276,558 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
620 | $35,724 |
All Filings in ABBV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $748,880 | 2,976 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $546,334 | 2,512 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $492,395 | 2,155 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $65,525 | 283 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $51,973 | 280 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $639,455 | 3,052 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $556,911 | 3,134 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $777,478 | 3,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $649,546 | 3,787 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $691,069 | 3,795 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $707,747 | 4,567 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $832,500 | 5,585 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $349,893 | 2,597 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $385,834 | 2,421 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $376,712 | 2,331 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $366,661 | 2,732 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $442,326 | 2,888 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $293,094 | 1,808 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $43,057 | 318 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $27,830 | 258 | Shares | Sole | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||